RegGenome’s vision is to transform the way the world consumes regulatory information.
Regulatory Genome Development has raised €5.5M across 1 funding round from 4 investors, most recently a Seed round in Apr 2022. Based in Cambridge, UK; active in Software. Data as of 6 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-04-12 | Seed |
| €5.5M |
| AlbionVC,Cambridge Enterprise,Evolution Equity Partners,Mastercard |
| View deal → |
